Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹1000
-
Expense Ratio
2.47
-
NAV
₹17.04
-
Fund Started
27 Jun 2023
-
Fund Size
₹351.89 Cr
-
Exit Load
Exit load of 1%, if redeemed within 15 days.
-
1 Year
4.96%
-
3 Year
-
-
5 Year
-
-
Equity
88.96%
-
Cash
5.11%
-
Top 10 Holdings
Zydus Wellness Ltd. | 9.27% |
Anthem Biosciences Ltd. | 9.17% |
Aster DM Healthcare Ltd. | 8.90% |
SMS Pharmaceuticals Ltd. | 8.86% |
Viyash Scientific Limited | 8.62% |
Alivus Life Sciences Ltd | 7.27% |
HFCL Ltd. | 7.14% |
Pfizer Ltd. | 6.42% |
Aurobindo Pharma Ltd. | 5.15% |
ICICI Prudential Life Insurance Company Ltd. | 4.35% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
-
Launch Date
27 Jun 2023
-
